BIOHEART-B (02185.HK) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Nov26

Iberis® Multipolar Renal Artery Radiofrequency Ablation Catheter System Completes Registration in New Zealand by Shanghai Aiton Medical Technology

11:10

Oct23

Biotronik's Affiliate's Iberis® RDN System Completes First Commercial Surgery in Switzerland

11:51

Aug26

BIOHEART-B released FY2025 Q1 earnings on August 26 (BJT) with actual revenue of HKD 11.17 M and EPS of HKD -0.0598

15:00

BIOHEART-B released FY2025 Q2 earnings on August 26 After-Market BJT, actual revenue HKD 11.42 M, actual EPS HKD -0.0611

11:00

BIOHEART-B released FY2025 Semi-Annual Earnings on August 26 After-Market BJT, actual revenue HKD 22.59 M, actual EPS HKD -0.121

11:00

Aug18

BIOHEART-B to Release FY2025 Semi-Annual Earnings on August 26, 2025 (BJT)

01:20

Schedules & Filings

Schedules

Filings

Aug26

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 11.42 M, Net Income -14.89 M, EPS -0.0611

Mar28

Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Net Income -33.04 M, EPS -0.1357

Aug19

Earning Release(CST)

FY2024 Q2 Earning Release (HKD) Net Income -13.88 M, EPS -0.057

View More

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change

View More